SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gao seng who wrote (526)6/30/2000 1:41:02 PM
From: allen menglin chen  Read Replies (1) of 746
 
Steve Newby, Genomicsfund.com

Author Dwivedi
Report Source Steve Newby
(Added 6/30/2000 6:12:54 AM)Categories: Sector Reports, Stock Picks

Email link to this Article

Steve Newby, Genomicsfund.com: CRA

Steve Newby, Founder of Genomicsfund.com, comments on the sector:

-Fund is pure genomic play; tremendous potential in this industry and one of its kind fund

-Trying to find the very best names and top tier stocks in the genomics area, particularly among: genomic delivery tech; tools; pharma-genomics; and, database

-Beginning of the genomics age

-Stock picks:

CRA: map of the human genome shows the competitive ability of scientists at CRA; annotation of genomic code to follow; co. signing up customers fast, with three new deals this week; moving ahead towards profitability
netcognizance.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext